IntegriChain, a leading Life Sciences data, and managed services company that helps drive access to life-saving and life-changing medicines, announced that it has acquired Cumberland’s Life Science Division, a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management. This acquisition marks IntegriChain’s fourth expansion since entering its strategic partnership with Accel-KKR, a leading technology-focused private equity firm, in 2016.
With this acquisition, IntegriChain delivers the Life Science industry’s most comprehensive and scalable data and business process platform for the commercialization and market access of cell and gene therapy, specialty, and retail pharmaceuticals.
IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 220 manufacturers rely on IntegriChain’s analytics, applications, managed services and expert advisors to power their market access operations and harness the value of their channel, patient and payer data.
The entire leadership and all employees of the Life Sciences Division of Cumberland team have joined IntegriChain, creating a global workforce that spans more than 350 professionals, including 120 dedicated contract operations and finance specialists and 80 advisory and systems integration consultants. IntegriChain and Cumberland Life Sciences customers should expect no changes or interruptions to the delivery of their solutions and servicing of their accounts.
Terms of Agreement
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Under terms of the agreement, IntegriChain acquired all assets of the Life Sciences Division of Cumberland. Moving forward, Cumberland will continue to serve the payer and provider markets by delivering healthcare advisory consulting services, technology services, and outsourced managed services. Financial details of the acquisition were not disclosed.
Source: HIT Consultant
